Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BTIG Downgrades Globus Medical to Neutral

BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.
byBenzinga Newsdesk
February 10, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0